OKT3- 1-ala-ala beneficial in new-onset type 1 diabetes

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1341, 2002-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GAD-alum: balanced results in new-onset type 1 diabetes

By  

Inpharma, Vol. 1, Iss. 1660, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Statins and New-Onset Diabetes

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3657-3664

Bentham Science Publishers

Access to resources Recommend Favorite

TRX 4 preserves residual -cell function in new-onset type 1 DM

By  

Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Targeting Type 1 Diabetes Before and at the Clinical Onset of Disease

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 103-124

Bentham Science Publishers

Access to resources Recommend Favorite

The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes

By Holstein Judith Dina   Kovacs Peter   Patzer Olaf   Stumvoll Michael   Holstein Andreas  

Pharmacogenomics, Vol. 13, Iss. 1, 2012-01 ,pp. : 5-7

Future Medicine

Access to resources Recommend Favorite